NHS genetic blood matching programme gives sickle cell patients hope
The NHS has launched a genetic blood matching programme to improve transfusions for sickle cell patients, reducing complications and helping people like Trey Henry Adegory.
The Full Story
A plain summary built from the channels that reported this story.
The NHS has introduced a world-leading genetic blood matching programme for sickle cell patients, designed to make blood transfusions safer and more effective. The programme tests a patient's blood type in greater detail, allowing transfusions to be genetically matched, which can reduce the risk of severe reactions and complications.
Sickle cell disease affects the shape of red blood cells and can cause intense pain, organ damage and strokes. Many patients require regular blood transfusions, but repeated transfusions can lead to the body developing antibodies against foreign blood groups. This can make future transfusions difficult, and in some cases, patients may not be able to receive blood at all.
Trey Henry Adegory, one of the first patients to benefit from the new testing, spoke about his experience. He lives with sickle cell and takes morphine daily to manage pain. He was diagnosed at birth and had a mini stroke at age nine. Since receiving genetically matched blood transfusions every four to five weeks, he says his pain is much less severe and he has been able to stay out of hospital. He has even started a clothing brand called Guarded.
The programme is particularly important for patients from black communities, who are more likely to have sickle cell and also more likely to develop antibodies. There is a historical shortage of blood donors from black communities, and the NHS is urging more people from these communities to donate blood and to get tested for the new genotyping.
Trey emphasised the importance of testing and donation, saying that it would help people like him tremendously. The programme offers hope for better management of the condition and a better quality of life for many patients.
On screen
Stills are sampled automatically at 60-second intervals. Where shown, the still is the nearest available frame from the relevant broadcast segment and is included to show what was on screen during that part of the broadcast. A still may not correspond to the exact second of a quoted phrase.
Key Claims
Claims reported during this story's coverage, mapped by channel. Ordered by how many channels carried each claim.
| Claim | ITV |
|---|---|
| Most patients who cannot receive any blood are from the black community and have sickle cell. | |
| Regular transfusion patients, especially those with sickle cell, can develop antibodies that cause severe reactions and complicate future transfusions. | |
| The NHS launched a world-leading programme to genetically match blood transfusions by testing patients' blood type. |
Channel Perspectives
What each channel focused on, with key quotes.
ITV1 focused on the human impact of the new NHS programme, featuring a live interview with a patient who has already benefited. The tone was hopeful and personal, highlighting the practical difference the genetic matching makes in daily life, while also using the patient's story to appeal for more blood donors from black communities.
- “We know that people who receive regular transfusions, particularly those with sickle, develop antibodies. So their body recognises as foreign additional blood groups that most of our bodies actually ignore.”
- “It's helping me stay out of hospital and just get on with my life. I've started a new business called Guarded which is a clothing brand and I'm excited for the future.”
- “If you're a person of ethnicity it's extremely important that you get tested for this new genotyping. It would help people like me and other people with sickle cell tremendously.”
Broadcast Timeline
News broadcasts tracked for this story, in time order.